Seeking Alpha

Jazz Pharmaceuticals (JAZZ +7.9%) double up on its AH gain yesterday following its upward...

Jazz Pharmaceuticals (JAZZ +7.9%) double up on its AH gain yesterday following its upward revision for 2012 revenue. Adding to the momentum, analysts at Muzho upped their price target on shares to $62 from $52 based on the firm's rosy outlook.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs